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scope level by measuring the change in the percentage of
cytoplasm that the myofilaments occupy, expressed as
%Vvmyo.3,4 The myofilaments of phenotypically modulated
SMCs in the media of injured arteries occupy less of the
cytoplasm, and there is a related increase in the area of cyto-
plasm occupied by organelles of synthesis. In vitro studies
indicate this modulation in the ultrastructural phenotype is
associated with a fundamental principle of SMC biology (ie,
SMCs in the low %Vvmyo [“synthetic”] state are more able
to proliferate, migrate, respond to growth factors, take up
lipids, and synthesize matrix proteins than SMCs in the high
%Vvmyo [“contractile”] state).6 Thus, the ultrastructural
phenotype is closely related to cell function. Various
cytoskeletal protein components of the myofilaments, such
as smooth muscle α-actin7 and smooth muscle myosin heavy
chain,8 have also been used as markers of smooth muscle
phenotype.9,10,11 Changes in synthesis of these proteins7,12
correlate with ultrastructural phenotype better than the pro-
tein levels, because of their relatively long protein half-life,9
and rapid reorganization of the cytoskeletal framework is also
a factor in this modulation of cell function.13
Alteration of SMC phenotype is central to the devel-
opment of a neointima in acutely injured arteries and to
The phenotypes of vascular smooth muscle cells
(SMCs) cover a broad spectrum. In the mature arterial wall,
the primary function of SMCs is contraction, and there is a
very low rate (< 0.1%) of cell replication.1 These cells have
an extensive contractile apparatus that dominates the cyto-
plasm.2-4 Although arterial SMCs are responsible for main-
tenance of their surrounding matrix in the normal adult
state, actual matrix turnover, like cell turnover, is low.5
After injury to the arterial wall, the SMCs undergo a
modulation in phenotype characterized by a loss of myofila-
ments. This phenotypic alteration, known to occur within 7
days after injury, can be quantified at the electron micro-
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BASIC RESEARCH STUDIES
Relationship of glycosaminoglycan and matrix
changes to vascular smooth muscle cell phenotype
modulation in rabbit arteries after acute injury
John A. Bingley, PhD, Ian P. Hayward, PhD, Gordon R. Campbell, PhD, and Julie H. Campbell, PhD,
Brisbane, Queensland, Australia.
Purpose: The phenotype of vascular smooth muscle cells (SMCs) is altered in several arterial pathologies, including the
neointima formed after acute arterial injury. This study examined the time course of this phenotypic change in relation
to changes in the amount and distribution of matrix glycosaminoglycans.
Methods: The immunochemical staining of heparan sulphates (HS) and chondroitin sulphates (CS) in the extracel-
lular matrix of the arterial wall was examined at early points after balloon catheter injury of the rabbit carotid
artery. SMC phenotype was assessed by means of ultrastructural morphometry of the cytoplasmic volume fraction
of myofilaments. The proportions of cell and matrix components in the media were analyzed with similar mor-
phometric techniques.
Results: HS and CS were shown in close association with SMCs of the uninjured arterial media as well as being more
widespread within the matrix. Within 6 hours after arterial injury, there was loss of the regular pericellular distribution
of both HS and CS, which was associated with a significant expansion in the extracellular space. This preceded the change
in ultrastructural phenotype of the SMCs. The glycosaminoglycan loss was most exaggerated at 4 days, after which time
the HS and CS reappeared around the medial SMCs. SMCs of the recovering media were able to rapidly replace their
glycosaminoglycans, whereas SMCs of the developing neointima failed to produce HS as readily as they produced CS.
Conclusions: These studies indicate that changes in glycosaminoglycans of the extracellular matrix precede changes in
SMC phenotype after acute arterial injury. In the recovering arterial media, SMCs replace their matrix glycosamino-
glycans rapidly, whereas the newly established neointima fails to produce similar amounts of heparan sulphates. (J Vasc
Surg 2001;33:155-64.)
early changes of atherogenesis.10,11 What induces this phe-
notypic modulation in the arterial SMCs is currently
unknown. It has been proposed that SMCs are maintained
in their “contractile” phenotype by pericellular heparan
sulphate proteoglycans.2 Certainly, the glycosaminoglycans
heparin and heparan sulphates inhibit SMC proliferation
and migration in vitro and neointimal formation in
vivo.14,15,16 Also, heparan sulphate proteoglycans from
normal rabbit aortae prevent SMC proliferation in vitro by
preventing the change in ultrastructural phenotype, and
neointimal formation in vivo is reduced by topically applied
heparan sulphate proteoglycans after arterial injury.17 The
current studies were performed to identify the timing of
the initial phenotype change within the media of the
injured artery in relation to alterations in amount and dis-
tribution of the matrix glycosaminoglycans.
MATERIALS AND METHODS
Animal surgery. Anesthesia was induced in 32 rabbits
with intravenous propofol (10 mg/kg; Diprivan ICI
Pharmaceuticals, Melbourne, Australia) and maintained
with halothane (Fluothane, ICI Pharmaceuticals,
Macclesfield, England). Surgery was performed through a
midline incision made in the animal’s neck, and the com-
mon carotid artery was exposed by means of blunt dissec-
tion. A 2F Fogarty embolectomy catheter (Baxter
Healthcare, Brisbane, Australia) was inserted in the com-
mon carotid artery via a branch of the external carotid,
inflated until resistance to withdrawal was felt, and with-
drawn against resistance along the entire length of the
common carotid artery to the bifurcation a total of three
times to ensure complete removal of the endothelium.3
Exposure of the distal common carotid ensured confirma-
tion of correct balloon inflation by means of visible dis-
tension of the artery. A broad-spectrum antibiotic (40
mg/kg Reverin; Hoechst, Melbourne, Australia) was
given as a single intramuscular injection at the end of the
procedure. All rabbits were fed normal rabbit chow and
given water freely until the end of the experimental period.
Animal care complied with the Guide for the Care and Use
of Laboratory Animals, and animal experiments were
approved by the University of Queensland Animal
Experimentation Ethics Committee.
Tissue collection and processing. At various points
after surgery (6, 12, and 24 hours; 2, 3, 4, 7, and 14 days;
and uninjured control subjects), four rabbits were killed
with an overdose of pentobarbitone (40 mg/kg Euthatal;
Animal Health, Victoria). Rabbit arteries were perfusion-
fixed by means of cardiac puncture at physiologic pressure
with 4% paraformaldehyde (Sigma Chem Co)/0.1% glu-
taraldehyde (Merck, Darmstadt, Germany) in 0.1 mol/L
phosphate buffer (PBS). The vessels were cut into 2- to 3-
mm rings and fixed in 4% paraformaldehyde/0.1% glu-
taraldehyde in 0.1 mol/L PBS for 2 to 4 hours. Vessels
with occlusive thrombus were excluded from analysis. For
embedding, the tissue was taken through graded alcohols
into LR White Hard resin and embedded at 40°C for 14
to 24 hours, or until the resin had set hard.
Microscopy. For light microscopy and immunohisto-
chemistry, semithin (0.7 µm) sections were cut from the
LR White blocks and placed on poly-L lysine-coated glass
slides. Sections were stained with 0.1% toluidine blue
(Gurr; Hopkin and Williams, Essex, England) for routine
light microscopy. Photographs were taken with a Zeiss
Axiophot microscope by the use of the ×40 objective. For
immunohistochemistry, semithin tissue sections were sub-
ject to blocking with 0.5% casein in PBS (pH 7.6) before
sections were incubated with antibodies to heparan sul-
phate (10E4, Seikagaku Kyogo, Japan; requiring at least 1
N-sulphate residue as epitope18), chondroitin sulphate
(CS-56, Sigma, against chondroitin but not dermatan sul-
phate19), and α smooth muscle actin (1A4, Sigma) for 4
hours at room temperature. After incubation, the slides
were rinsed in 0.1 mol/L PBS. A biotinylated secondary
antibody, antimouse immunoglobulin-biotin (Silenus),
was then applied for 2 hours, and after the slides were
washed in 0.1 mol/L PBS, a third-level chromophore,
Streptavidin-Texas Red, was applied for 2 more hours.
After a final rinse, slides were cover-slipped with
Vectashield antifade mounting medium and immediately
examined with a Bio-Rad 1028 confocal microscope.
Control sections were incubated with a primary antibody
shown not to stain rabbit tissue (antimouse Ig).
Electron microscopy. Ultrathin (70 nm) sections were
cut on an ultratome (Ultracut E Reichert-Jung Microtome,
HD Scientific Supplies, New South Wales) and placed on
Formvar-coated single-slot copper grids. After the staining
with uranyl acetate and lead citrate, sections were examined
by using an EM10A/B electron microscope (Carl Zeiss, D-
7082 Oberkochen, Germany). Two nonadjacent areas
within the inner media of each section were selected for
photomicrographs at higher magnification after examina-
tion of the whole section at 1000× magnification.
Photographs were then taken of 5 SMCs at 10,000× mag-
nification from within each of the previously identified
regions; thus, a total of 10 micrographs were taken for each
arterial section. Sections were taken from a minimum of
three separate blocks for a minimum of three arteries at each
time point; in all, a minimum of 90 SMCs were examined
for each time point. Photographic plates were developed at
a standard enlargement size on 20.3 cm by 25.4 cm
Polymax photographic paper (Kodak, Rochester, NY).
SMC ultrastructural phenotype was assessed by mea-
suring the relative proportion of myofilaments within the
cytoplasm in each cell.3 Point-counting morphometry was
performed as a manual measurement by using a 21 cm by
26 cm (546 point) transparent grid placed over the micro-
graph. The sum of all points lying over cytoplasmic myofil-
aments were expressed as a proportion of the total number
of cytoplasmic points by using this formula:
%Vvmyo = (number of myofilament points/number
cytoplasm points) × 100.
Morphometric analysis of the proportions of arterial
media occupied by elastin, SMC, and nonelastin matrix was
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determined as percentages of the total field area.20 Fields
containing two or more necrotic SMCs were excluded from
medial area analysis, because corresponding losses from the
other medial components (elastin and nonelastin matrix) do
not occur. Average %Vvmyo and % medial component areas
were thus determined for each time point, and comparisons
were made between the time points by means of one-way
analysis of variance (ANOVA) with Sigma-Stat software
(Jandel Scientific). For non-normal distributions, compar-
isons were made with one-way ANOVA on ranks.
RESULTS
Uninjured rabbit carotid artery. A normal rabbit
carotid artery consisting of a thin intima with a single layer
of endothelial cells lying closely associated with the inter-
nal elastic lamina was shown by means of light microscopy.
The medial SMCs within the normal artery were arranged
primarily with their long axes lying circumferentially.
Immunohistochemistry revealed heparan sulphates (Fig 1,
a) and chondroitin sulphates (Fig 1, b) located extracellu-
larly, with heparan sulphates being more closely confined
to the immediate pericellular region of the SMCs, whereas
chondroitin sulphates were more widely distributed
throughout the matrix.
With the electron microscope, the uninjured arterial
medial SMCs were shown to be elongated cells with a sub-
stantial amount of their cytoplasm filled by contractile
apparatus. The SMCs were in close association with the
adjacent elastic laminae for a large part of their length,
with close association with dense bodies on the cytoplas-
mic side of the membrane. The space between SMCs was
relatively small, with an occasional cellular contact seen.
Rabbit carotid artery after injury. After arterial
injury, there was a loss of endothelium in all sections
viewed, and a variable degree of medial damage existed.
The elastic lamellae remained intact but were slightly frag-
mented. With time, the SMCs were seen to progressively
alter in size, shape, and orientation, compared with the
uninjured arterial media. They no longer lay with their
long axes circumferential, but were more polygonal and
displayed occasional perinuclear lucent spaces. By 7 days
the first signs of neointimal formation occurred, with
SMCs lying one to two cells deep within the bounds of the
internal elastic lamina. At 14 days, the neointima was seen
to develop further.
Altered distribution of both heparan sulphates and
chondroitin sulphates within 6 hours after injury was
shown by immunohistochemistry, such that the neat peri-
cellular arrangement of both glycosaminoglycans was lost.
Within 4 days after injury, the distributions of heparan sul-
phate (Fig 2, a) and chondroitin sulphate (Fig 2, b) were
substantially modified, with neither sugar readily
detectable in the orderly pericellular distribution seen pre-
viously. At 7 days after injury, the medial SMCs were again
surrounded closely by both heparan and chondroitin sul-
phates, although recovery was variable. The neointima at
7 days, despite having little extracellular space, stained
heavily for chondroitin sulphate, but not heparan sul-
phate. At 14 days after injury, the medial heparan and
chondroitin sulphates were of a similar distribution to that
seen in the uninjured arterial media. At this point, the
neointima again showed only light staining for heparan
sulphates (Fig 3, a), but stained heavily for chondroitin
sulphates (Fig 3, b).
Fig 1. Normal rabbit carotid artery in cross section. a, Immunochemistry showing distribution of heparan sul-
phates. Primary antibody against heparan sulphates (10E4 Seikagaku Kyogo, Japan; requiring at least 1 N-sulphate
residue as epitope18) visualized with Texas Red. b, Chondroitin sulphate distribution with primary antibody detect-
ing CS-4 and CS-6 sulphates (CS56, Sigma) visualized with Texas Red. Arrows indicate internal elastic lamina.
Alterations in the normal relationship between SMCs
and the extracellular matrix not seen at the light micro-
scope level were revealed by electron microscopy. As early
as 6 hours after injury, SMCs dissociated from their previ-
ous close relationship with the elastic lamellae, although no
discernible alteration in the ultrastructural phenotype
occurred at this time. Within 48 hours after injury, the con-
tractile apparatus gradually formed into more or less dis-
creet bands running obliquely along the long axis of the
cell (Fig 4, a). Synthetic organelles were located predomi-
nantly in the perinuclear region, similar to those of SMCs
in the uninjured artery. Associated with these changes was
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Fig 2. Immunochemistry showing glycosaminoglycan distributions in rabbit carotid artery cross sections 4 days after
injury. a, Heparan sulphates (antibody 10E4) visualized with Texas Red at 4 days. b, Chondroitin sulphates (antibody
CS56) visualized with Texas Red at 4 days. Arrows indicate internal elastic lamina.
Fig 3. Immunochemistry showing glycosaminoglycan distributions in rabbit carotid artery cross sections 14 days
after injury. a, Heparan sulphates (10E4) visualized with Texas Red at 14 days. b, Chondroitin sulphates (CS56)
visualized with Texas Red at 14 days. Arrows indicate internal elastic lamina.
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a decrease in the proximity between the SMCs and their
adjacent elastic laminae; the SMCs remained tethered to
the elastic laminae at points, rather than broad regions of
contact. At 4 days, the change in the size, shape, and rela-
tionship of cells to each other and the elastic laminae was
most evident (Fig 4, b). There was some heterogeneity in
the appearance of the myofilament architecture. In most of
the SMCs, the myofilaments were densely packed; these
cells appeared much smaller and more completely dissoci-
ated from the elastic laminae. In those cells in which the
myofilaments resembled more than those seen in SMCs at
earlier times, the bands of myofilaments were more dis-
cretely formed, and throughout the cytoplasm between
these bands of filaments were cytoplasmic organelles, endo-
plasmic reticulum, vesicles, and mitochondria. These cells,
and a minority of SMCs in which the contractile apparatus
Fig 4. Electron photomicrographs showing smooth muscle cells (SMCs; ×1000) in rabbit carotid artery cross sec-
tions at various points after injury. a, At 2 days, SMCs have contracted away from elastic lamellae. b, At 4 days,
SMCs appear smaller and dissociated from elastic lamellae. c, At 7 days, SMCs increased in size and were reassoci-
ating with elastic lamellae. e, Elastic lamellae; m, nonelastin matrix.
appeared as a diffuse mesh of low electron density, were
more closely associated with the elastic laminae than the
small SMCs with densely packed myofilaments. At this
stage, there were no neointimal cells.
At 7 days after injury, the contractile apparatus of the
SMCs had undergone a further obvious change, with most
SMCs containing myofilaments in a sparsely arranged
mesh (Fig 4, c). The SMCs were also larger in size and had
reestablished their close association to the elastic laminae.
In a few sites, possibly those of more severe injury, the
SMCs remained as small, shrunken cells with no close
association to the adjacent elastic laminae. Cells now also
appeared within the boundary of the internal elastic lam-
ina, forming the early neointima. Although the %Vvmyo
of these SMCs was not measured, they were seen to be of
a “synthetic” phenotype, filled predominantly with syn-
thetic organelles—endoplasmic reticula, Golgi apparatus,
and mitochondria.
At 14 days, there were no longer medial SMCs that
appeared tightly contracted and unassociated with the
elastic laminae; the vast majority of the SMCs had reestab-
lished their intimate contact with the elastic laminae of the
arterial media. The large amounts of extracellular space
between medial SMCs had mostly disappeared, and the
media resembled the normal arterial media.
Analysis of the SMC ultrastructural phenotype by
means of point-counting morphometry showed there was
a gradual reduction in the amount of SMC cytoplasm
occupied by the contractile apparatus (Fig 5). The SMCs of
the normal arterial wall had most of their cytoplasm com-
posed of myofilaments, as indicated by a high %Vvmyo
(71.0 ± 0.8). This cytoplasmic volume fraction of myofila-
ments then reduced progressively, with the difference
becoming significant at 24 hours after injury (P < .01). At
2 days after injury, there was a further reduction in the
amount of cytoplasm occupied by myofilaments (%Vvmyo,
54.2 ± 1.0). By day 4, the SMCs of the arterial media were
clearly of an altered phenotype (%Vvmyo, 59.1 ± 1.3), and
at 7 days after injury, the ultrastructural phenotype of the
SMCs was most changed (%Vvmyo, 45.4 ± 1.1). There was
no significant change in SMC ultrastructural phenotype
between 7 and 14 days after injury; the SMCs remained in
the modulated phenotype (%Vvmyo, 50.0 ± 1.7).
Changes in the contribution of each component of the
media to the overall cross-sectional area were measured. In
the uninjured artery, the SMCs occupied 49.0% ± 0.9% of
the total area (Fig 6). At 6 hours after injury, the SMCs
occupied significantly less of the medial area (35.0% ±
1.5%). This reduced further at 2 days (26.0% ± 1.5%) and
remained at this nadir at 4 days after injury (29.0% ±
2.3%). By 7 days after arterial injury, the SMCs had signif-
icantly increased their overall occupancy of the arterial
medial area (40.0% ± 2.7%), compared with that at 2 days
(P < .05), a proportion which remained unchanged at 14
days (35.0% ± 2.4%). At all points until 14 days after
injury, the SMCs occupied a significantly smaller area of
the arterial wall than in the uninjured artery (P < .0001;
one-way ANOVA on Ranks, unequal variance).
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Fig 5. Histogram showing ultrastructural phenotype of rabbit
carotid artery medial smooth muscle cells (SMCs) at various times
after injury. Ultrastructural SMC phenotype was measured by
means of point-counting morphometry to determine the cyto-
plasmic volume fraction of myofilaments (%Vvmyo), expressed as
means (± SE). All points beyond 6 hours were significantly dif-
ferent from the control (P < .05).
Fig 6. Histogram showing the contribution of smooth muscle cells
(SMCs) to overall medial cross-sectional area at various times after
injury. The percentage areas were measured by means of point-
counting morphometry and expressed as means (± SE). *Control
significantly greater than all injured artery time points (P < .05).
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In the uninjured artery, the elastic laminae occupied
21.0% ± 0.8% of the total medial area (Fig 7). There was
no significant change at 6 hours (22.0% ± 1.3%), 2 days
(23.0% ± 1.7%), or 4 days (20.0% ± 1.2%) after arterial
injury. At 7 days, however, there was a significantly smaller
percentage of the artery wall occupied by elastin (17.0% ±
0.6%), compared with the uninjured artery and at both 6
hours and 2 days after injury (P < .01). By 14 days after
injury, there was again no difference from uninjured or
injured artery at early points in the percentage of total
medial area occupied by elastin (19.0% ± 1.1%).
There were significant changes to the nonelastin matrix
from as early as 6 hours after injury (Fig 8). In the uninjured
arterial wall, the matrix surrounding the SMCs (excluding
the elastic laminae) occupied 30.0% ± 1.0% of the overall
arterial wall area. Within 6 hours, this extracellular space had
expanded to 44.0% ± 1.5% of the total area and continued to
expand to a peak at 2 to 4 days (52.0% ± 2.5% and 51.0% ±
2.9%, respectively). This space was reduced by 7 days (43.0%
± 2.5%) and remained largely unchanged at 14 days (46.0%
± 3.1%). Measurements for all points were significantly dif-
ferent from the uninjured vessel (P = .004). The decrease in
the percentage of the arterial wall occupied by SMCs and the
corresponding increase in the nonelastin matrix appeared to
be caused by a number of factors, including edema, some
decrease in SMC cell size and number, and an increase in
collagen matrix synthesis. The total area of the media
showed a slight but not significant increase in 14 days.
DISCUSSION
For SMCs to contribute to the formation of a neoin-
tima, they must first migrate from the media and prolifer-
ate, and this requires modulation of phenotype.2
Although it is known that SMCs undergo a modulation in
phenotype within 7 to 14 days after injury,3,4 the precise
sequence of ultrastructural changes before 7 days after
injury had not previously been quantified. Cell loss is
observed within hours after injury, and evidence of both
necrosis3,21 and apoptosis22 has been reported. The major
glycosaminoglycans, chondroitin sulphate and heparan
sulphate, are lost from the extracellular matrix before any
measurable modulation in phenotype, and this may be an
important requisite step in SMC phenotypic modulation,
as suggested by our earlier in vitro studies.23 The time
course of change within the first 7 days after injury is con-
sistent with that observed for the appearance of prolifera-
tive cells. Entry of medial SMCs into the cell cycle is
observed within hours after injury, with maximal prolifer-
ative indices in the media anywhere from day 2 to day 5,
depending on the injury model.1,24 Smooth muscle α-
actin levels in the media, which have also been used as a
marker of SMC phenotype, are most decreased at day 5 in
the rat injury model, with earlier change only seen in the
cells that have begun to proliferate.7 Likewise, the pro-
gressive decrease in %Vvmyo, which measures the average
phenotype for the medial SMC population, indicates that
Fig 7. Histogram showing the contribution of elastic lamellae,
including internal elastic lamina, to overall medial cross-sectional
area at various times after injury. The percentage areas were mea-
sured by means of point-counting morphometry and expressed as
means (± SE). *Significantly different from the control (P < .05).
Fig 8. Histogram showing the contribution of extracellular matrix
(excluding elastic components) to overall medial cross-sectional
area at various times after injury. The percentage areas were mea-
sured by means of point-counting morphometry and expressed as
means (± SE). *Control significantly less than all injured artery
time points (P < .05).
a proportion of the population undergoes early change,
within 24 hours after injury, with a maximal decrease over
the entire media by day 7. By using immunohistochem-
istry for smooth muscle α-actin, we observed little change
in intensity of positive staining of the SMCs in the media
over this time (results not shown).
By 7 and 14 days after injury, there are two different
groups of SMCs to consider, medial SMCs and SMCs
forming the early neointima. SMCs of the neointima
appear smaller, remain rounded, and are unable to estab-
lish contact with preexisting matrix structures because
none exists. In this, they are in a similar state to SMCs
placed in primary culture, which also display an altered
phenotypic state.6 We previously quantitated the ultra-
structural phenotype of medial and intimal SMCs at 2, 6,
and 18 weeks after injury,3 and our 2-week data here are
consistent with that study. Medial SMCs have a decreased
%Vvmyo, but return to the “contractile” phenotype within
6 weeks after injury. There are too few intimal cells at 7
days to quantitate %Vvmyo. At 2 and 6 weeks, the intimal
SMC %Vvmyo is slightly lower than that of medial SMCs,
although luminal SMCs continue to have a very low
%Vvmyo even after 18 weeks.3
The SMC is the only cell in the normal arterial
media,25 and it contributes entirely to the arterial media’s
construction from early embryo to the mature adult
artery. In atherosclerosis, the SMC is the primary cell of
the fibromuscular plaque, especially of the fibrous cap and
important shoulder regions, where instability of the
atherosclerotic plaque is now thought to occur.2,26 When
the arterial wall is injured, the healing response, which is
readily comparable with wound healing seen in other con-
nective tissues,27 depends on the SMCs; the SMC assumes
the role of the fibroblast for the arterial wound.
Extracellular matrix surrounds the SMCs, and several
matrix components, the major groups of which are the
collagens, elastin, and proteoglycans, are known to influ-
ence SMC phenotype.28,29 Arterial tissue is particularly
rich in proteoglycans.30,31 The reduction of both chon-
droitin and heparan sulphates at the early points after
acute injury suggests an active degradation of gly-
cosaminoglycans within the arterial media. Such activity is
known for many of the metalloproteinases,5 including the
stromelysins (MMP 3) that degrade proteoglycan core
proteins, and we have recently described both metallopro-
teinase (including MMP 3) activity and heparan sulphate
degrading activity (heparanase) induced during the first
week after injury in this model.32
There is an overall increase in glycosaminoglycan pro-
duction seen when SMCs modulate from the mature non-
proliferative to the proliferative phenotype. “Synthetic”
state SMCs produce more than twice the amount of total
sulphated glycosaminoglycans than “contractile” SMCs in
vitro.33 Similar changes occur in vivo. Three days after bal-
loon injury, incorporation of 35S-sulphate is 2.5 times
higher in arteries, decreasing to 1.8 times after 7 days, and
returning to uninjured levels at 14 days,34 with most of the
increase in glycosaminoglycan synthesis occurring in the
chondroitin sulphate fraction. The SMCs of the early neoin-
tima are shown in our studies to elaborate chondroitin sul-
phates densely within the matrix, while producing less
heparan sulphates than the SMCs of the underlying media.
SMCs are particularly sensitive to the antiproliferative
effects of the heparan sulphate proteoglycans and related
compounds.14,35,36 The heparan sulphate proteoglycan
fraction from the aortic wall, but not chondroitin sulphate
proteoglycans, is potently inhibitory of SMC proliferation
in vitro through an inhibition of SMC phenotype
change.17 Given the intimate relationship between
heparin/heparan sulphates and the inhibition of vascular
SMC proliferation, it has been hypothesized that the
degradation of pericellular heparan sulphates by hepariti-
nase action in the injured artery is an early mechanism in
SMC phenotype change.23 The data we present here are
consistent with this hypothesis, because the degradation of
heparan sulphates from the matrix surrounding the medial
SMCs occurred as early as 6 hours after injury and pre-
ceded the change in SMC phenotype. Hein et al37 demon-
strated matrix from adult rat aortic SMC cultures to be
more inhibitory of SMC proliferation than matrix from rat
neonatal or neointimal SMCs and that the inhibitory
potential of these matrices depended on the heparan sul-
phate (but not chondroitin sulphate) component.
Moreover, SMCs that have returned to their quiescent
phenotype produce heparan sulphates, which assist in
maintenance of that quiescence.38,39 Not only do SMCs in
differing phenotypes produce different heparan sulphates,
but quiescent SMCs are 50 to 100 times more sensitive to
the inhibitory effects of heparan sulphates than SMCs in
the proliferative state.40
Chondroitin sulphates do not have the same growth
inhibitory potential for SMCs as heparan sulphates.
Chondroitin sulphate proteoglycans in the normal aorta
decrease in concentration from the intima to the outer
media.41-43 Large chondroitin sulphate proteoglycans near
the internal elastic lamina bind in a meshwork with
hyaluronic acids and assist in hydration of the matrix in a
manner similar to that in cartilage.42,44 The swelling of the
extracellular space in part represents edema of acute
inflammation and reflects the role chondroitin sulphates
play in arterial wall hydration. The smaller chondroitin
sulphate proteoglycans biglycan and decorin45 are found
throughout the media, where they associate with collagen
fibrils and the microfibrillar elements of elastin, although
not the bulk of the amorphous elastin sheet.44 The loss of
chondroitin sulphates, like that of heparan sulphates, coin-
cides with changes in the relative contributions made by
SMCs and the non-elastin extracellular spaces to the over-
all wall cross-sectional areas. 
There is undoubtedly a physical dimension to the
interaction between SMCs and matrix, and the consider-
able dynamic forces acting on the SMCs are likely to pro-
mote quiescence in the SMCs in vivo.46 Cyclic stretching
in vitro impels SMCs to maintain features particular to
SMCs.47 In contrast, passive tension results in a series of
degenerative changes, in which the cells lose their SMCs
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characteristics in culture.48 There is considerable strength
of the bond between the SMCs and elastin; when dis-
tended at higher than physiological pressure, the SMCs
will rupture before the bond between the dense body and
elastin breaks.49 Yet after acute injury, this tight bond is
broken over the first 2 to 4 days after injury, suggesting
degradation of the anchoring elements, possibly by
enzymes such as metalloproteinases that are found to be
increased after balloon catheter injury.32 The SMCs do
certainly dissociate from their normal contact with the
elastic lamellae,49 and, in doing so, they appear to contract
in a manner suggesting a loss of opposing tensile force. It
is possible that chondroitin sulphates, by connecting
SMCs to the arterial matrix, assist in maintaining the phe-
notype of the SMCs in the artery wall, and their loss alters
the usual mechanical forces acting on SMCs. In this con-
text, it has recently been shown that overaccumulation of
dermatan sulphate in the artery wall inhibits elastic fiber
formation by interacting with the elastin-binding protein
that acts as a molecular chaperone for tropoelastin.50
The SMC and its matrix clearly have a complex
dynamic interaction. This is well demonstrated in the case
of the glycosaminoglycans. After injury, the heparan and
chondroitin sulphates of the matrix surrounding the SMCs
are rapidly lost, with subsequent release of the SMCs from
their mature nonproliferative phenotype. Although the
mechanism of action for heparan sulphates in SMC biology
has been extensively explored in vitro, the actions of chon-
droitin sulphate may be just as important in vivo. Glycos-
aminoglycans represent a component of the matrix that can
undergo rapid degradation and synthesis after injury, and
their presence may play an important role in the mainte-
nance of normal arterial wall architecture and SMC pheno-
type. Inhibition of these changes may thus offer an avenue
for limiting the proliferative response to injury.
REFERENCES
1. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation
after arterial injury, I: smooth muscle growth in the absence of
endothelium. Lab Invest 1983;49:327-33.
2. Campbell GR, Campbell JH. Smooth muscle phenotypic changes in
arterial wall homeostasis: implications for the pathogenesis of athero-
sclerosis. Exp Mol Pathol 1985;42:139-62.
3. Manderson JA, Mosse PRL, Safstrom JA, Young SB, Campbell GR.
Balloon catheter injury to rabbit carotid artery, I: changes in smooth
muscle cell phenotype. Arteriosclerosis 1989;9:289-98.
4. Thyberg J, Blomberg K, Hedin U, Dryjski M. Phenotypic modulation
of smooth muscle cells during the formation of neointimal thickenings
in the rat carotid artery after balloon injury: an electron-microscopic
and stereological study. Cell Tissue Res 1995;281:421-33.
5. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of
matrix metalloproteinases and matrix degrading activity in vulnerable
regions of human atherosclerotic plaques. J Clin Invest 1994;94:
2493-503.
6. Campbell JH, Campbell GR. Culture techniques and their applica-
tions to studies of vascular smooth muscle. Clin Sci 1993;85:510-3.
7. Clowes AW, Clowes MM, Kocher O, Ropraz P, Chaponnier C,
Gabbiani G. Arterial smooth muscle cells in vivo: relationship between
actin isoform expression and mitogenesis and their modulation by
heparin. J Cell Biol 1988;107:1939-45.
8. Sartore S, Chiavegato A, Franch R, Faggin E, Pauletto P. Myosin gene
expression and cell phenotypes in vascular smooth muscle during
development, in experimental models, and in vascular disease.
Arterioscler Thromb Vasc Biol 1997;17:1210-5.
9. Owens GK. Regulation of differentiation of vascular smooth muscle
cells. Physiol Rev 1995;75:487-517.
10. Campbell JH, Campbell GR. Smooth muscle diversity: implications
for the question, what is a smooth muscle cell? Biomedical Research
1997;8:81-125.
11. Thyberg J. Phenotypic modulation of smooth muscle cells during for-
mation of neointimal thickenings following vascular injury. Histol
Histopathol 1998;13:871-91.
12. Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR.
Cytodifferentiation and expression of α-smooth muscle actin mRNA
and protein during primary culture of aortic smooth muscle cells: cor-
relation with cell density and proliferative state. Arteriosclerosis
1989;9:633-43.
13. Song J, Rolfe BE, Campbell JH, Campbell GR. Changes in three-
dimensional architecture of microfilaments in cultured vascular
smooth muscle cells during phenotypic modulation. Tissue Cell
1998;30:324-33.
14. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle
cell proliferation in injured arteries. Nature 1977;265:625-6.
15. Hoover RL, Rosenberg R, Haering W, Karnovsky MJ. Inhibition of
rat arterial smooth muscle cell proliferation by heparin: II: in vitro
studies. Circ Res 1980;47:578-83.
16. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ. Inhibition of
rat arterial smooth muscle cell proliferation by heparin. Circ Res
1980;46:625-34.
17. Bingley JA, Hayward IP, Campbell JH, Campbell GR. Arterial
heparan sulfate proteoglycans inhibit vascular smooth muscle cell pro-
liferation and phenotype change in vitro and neointimal formation in
vivo. J Vasc Surg 1998;28:308-18.
18. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe
H. Developmental changes in heparan sulfate expression: in situ
detection with mAbs. J Cell Biol 1992;119:961-75.
19. Avnur Z, Geiger B. Immunocytochemical localization of native chon-
droitin-sulfate in tissues and cultured cells using specific monoclonal
antibody. Cell 1984;38:811-22.
20. Glagov S, Grande J, Vesselinovitch D, Zarins CK. Quantitation of
cells and fibers in histological sections of arterial walls: advantages of
contour tracing on a digitizing plate. In: McDonald TC, Chandler
AB, editors. Connective tissues in arterial and pulmonary diseases.
New York: Springer-Verlag; 1981. p. 57-94.
21. Doornekamp FNG, Borst C, Post MJ. Endothelial cell recoverage and in-
imal hyperplasia after endothelium removal with or without smooth mus-
cle cell necrosis in the rabbit carotid artery. J Vasc Res 1996;33:146-55.
22. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid
onset of apoptosis in medial smooth muscle cells after balloon injury.
Circulation 1997;95:981-7.
23. Campbell JH, Rennick RE, Kalevitch SG, Campbell GR. Heparan sul-
fate-degrading enzymes induce modulation of smooth muscle pheno-
type. Exp Cell Res 1992;200:156-67.
24. Tanaka H, Sukhova G, Schwartz D, Libby P. Proliferating arterial
smooth muscle cells after balloon injury express TNF-a but not inter-
leukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc
Biol 1996;16:12-8.
25. Pease DC, Paule WJ. Electron microscopy of elastic arteries. The tho-
racic aorta of the rat. J Ultrastruct Res 1960;3:469-83.
26. Weissberg PL, Clesham GJ, Bennett MR. Is vascular smooth muscle
cell proliferation beneficial? Lancet 1996;347:305-6.
27. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for resteno-
sis based on cell biology: clues for the development of new preventa-
tive therapies. J Am Coll Cardiol 1991;17:758-69.
28. Hayward IP, Bridle KR, Campbell GR, Underwood PA, Campbell
JH. Effect of extracellular matrix proteins on vascular smooth muscle
cell phenotype. Cell Biol Int 1995;19:839-46.
29. Yamamoto K, Aoyagi M, Yamamoto M. Changes in elastin-binding
proteins during the phenotypic transition of rabbit arterial smooth
muscle cells in primary culture. Exp Cell Res 1995;218:339-45.
30. Wight TN. Cell biology of arterial proteoglycans. Arterioscler
Thromb Vasc Biol 1989;9:1-20.
31. Li Z, Alavi M, Wasty F, Galis Z, Moore S. Proteoglycan synthesis by
the neointimal smooth muscle cells cultured from rabbit aortic explants
following de-endothelialisation. Pathobiology 1993;61:89-94.
32. Fitzgerald M, Hayward IP, Thomas AC, Campbell GR, Campbell JH.
Matrix metalloproteinases can facilitate the heparanase-induced pro-
motion of phenotypic change in vascular smooth muscle cells.
Atherosclerosis 1999;145:97-106.
33. Merrilees M, Campbell JH, Spanidis E, Campbell GR.
Glycosaminoglycan synthesis by smooth muscle cells of differing phe-
notype and their response to endothelial cell-conditioned medium.
Atherosclerosis 1990;81:245-54.
34. Richardson M, Hatton MWC. Transient morphological and bio-
chemical alterations of arterial proteoglycan during early wound heal-
ing. Exp Mol Pathol 1993;58:77-95.
35. Castellot JJ Jr, Addonizio ML, Rosenberg R, Karnovsky MJ. Cultured
endothelial cells produce a heparin-like inhibitor of smooth muscle
cell growth. J Cell Biol 1981;90:372-9.
36. Karnovsky MJ, Wright TC, Castellot JJ, Choay J, Lormeau J-C,
Petitou M. Heparin, heparan sulfate, smooth muscle cells, and ather-
osclerosis. Ann N Y Acad Sci 1989;556:268-81.
37. Hein M, Fischer J, Kim DK, Hein L, Pratt RE. Vascular smooth mus-
cle cell phenotype influences glycosaminoglycan composition and
growth effects of extracellular matrix. J Vasc Res 1996;33:433-41.
38. Fritze LM, Reilly CF, Rosenberg RD. An antiproliferative heparan
sulfate species produced by postconfluent smooth muscle cells. J Cell
Biol 1985;100:1041-9.
39. Schmidt A, Buddecke E. Bovine aortic smooth muscle cells synthesize
two functionally different proteoheparan sulphate species. Exp Cell
Res 1990;189:269-75.
40. Reilly CF, Fritze LM, Rosenberg RD. Heparin inhibition of smooth
muscle cell proliferation: a cellular site of action. J Cell Physiol
1986;129:11-9.
41. Massaro TA, Glatz CE. Distribution of glycosaminoglycans in consec-
utive layers of rabbit aorta. Artery 1979;5:1-13.
42. McMurtrey J, Radhakrishnamurthy B, Dalferes ER, Berneson GS,
Gregory JD. Isolation of proteoglycan-hyaluronic acid complexes
from bovine aorta. J Biol Chem 1979;254:1621-6.
43. Couchman JR, Cateson B, Christner JE, Baker JR. Mapping by mon-
oclonal antibody detection of glycosaminoglycans in connective tis-
sue. Nature 1984;307:650-2.
44. Galis ZS, Alavi MZ, Moore S. In situ ultrastructural characterisation
of chondroitin sulfate proteoglycans in normal rabbit aorta. J
Histochem Cytochem 1992;40:251-63.
45. Rauch U, Glossl J, Kresse H. Comparison of small proteoglycans from
skin fibroblasts and vascular smooth muscle cells. Biochem J
1986;238:465-74.
46. Osol G. Mechanotransduction by vascular smooth muscle. J Vasc Res
1995;32:275-92.
47. Leung DY, Glagov S, Mathews MB. Cyclic stretching stimulates syn-
thesis of matrix components by arterial smooth muscle cells in vitro.
Science 1976;191:475-7.
48. Sottiurai VS, Kollros P, Glagov S, Zarins CK, Mathews MB.
Morphological alteration of cultured arterial smooth muscle cells by
cyclic stretching. J Surg Res 1983;35:490-7.
49. Clark J, Galgov S. Structural integration of the arterial wall. I.
Relationships and attachments of medial smooth muscle cells in normally
distended and hyperdistended aortas. Lab Invest 1979;40:587-602.
50. Hinek A, Wilson SE. Impaired elastogenesis in Hurler disease.
Dermatan sulfate accumulation linked to deficiency in elastin-binding
protein and elastic fiber assembly. Am J Pathol 2000;156:925-38.
Submitted Mar 2, 2000; accepted May 25, 2000.
JOURNAL OF VASCULAR SURGERY
164 Bingley et al January 2001
